ÌÇÐÄvlog¹ÙÍø

We measure whether expert patients – those trained as physicians and nurses – have fewer emergency department visits and the reasons for these differences. Relative to similar…

Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher…

Recent efforts to control spending, including accountable care organizations, value-based payment, and high-deductible health plans, have emphasized optimizing patterns of health…

There’s growing global interest in investing in disease prevention—not just to improve health but to cut health care costs. The idea seems simple: if people eat better, exercise…

The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first expected to result in a net reduction in…

The growth in spending on health care has slowed over the last decade, easing fears that Medicare would devour the federal budget, create crippling federal deficits, and cause…

The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary…

Notwithstanding concerns about staffing levels and burnout in health care, federal wage and employment data does not support the suggestion that a Covid-19 pandemic-related spike…

Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single…

The debate around prescription drug measures in the recently passed U.S. Inflation Reduction Act (IRA), which limit some patients’ out-of-pocket costs, has not fully addressed…